merck volunatrily recalled its blockbuster $2.5B arthritis drug vioxx after longstanding concerns about increased risk of heart disease and stroke were confirmed in a study ... merck (Dow: MRK) shares went into a tailspin on wall street, sending the dow jones index down with it.
this puts pfizer's celebrex at the top of the market. i suppose this is good news for folks over at pfizer .... !! the stock (PFE) would probably do well in the short term because of this announcement.